Tender notice
NHS National Framework for Transition products commencing 1 February 2025
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer
Public buyer
NHS EnglandTender value£11,328,000
- Planned startAs published in the notice
- Planned endAs published in the notice
Work description
Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:
CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection
Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk